Imaging strategy in recurrent ovarian cancer: a practical review.


Journal

Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 11 7 2018
medline: 21 4 2020
entrez: 11 7 2018
Statut: ppublish

Résumé

Ovarian cancer is one of the most aggressive gynaecologic malignancies in women worldwide. The lack of proper screening programs and the characteristic abdominal spreading with minimal clinical symptoms give rise of its high lethality. Most patients show advanced disease at diagnosis and have a poor prognosis. The surveillance of ovarian cancer patients after initial treatment is a challenging question in clinical practice and there is no consensus in literature about the most appropriate follow-up strategy for these women. The role of Imaging has become increasingly important, allowing to properly monitor patients, distinguishing the different relapse patterns, thus guiding the correct management and therapy. In this review, we report and analyze the scientific evidence about the role of the different imaging modalities now available in the follow-up strategy and management of Epithelial Ovarian Cancer patients with recurrent disease.

Identifiants

pubmed: 29987401
doi: 10.1007/s00261-018-1677-y
pii: 10.1007/s00261-018-1677-y
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1091-1102

Auteurs

Lucia Manganaro (L)

Department of Radiological, Oncological and Pathological Science, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. lucia.manganaro@uniroma1.it.

Silvia Gigli (S)

Department of Radiological, Oncological and Pathological Science, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

Amanda Antonelli (A)

Department of Radiological, Oncological and Pathological Science, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

Matteo Saldari (M)

Department of Radiological, Oncological and Pathological Science, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

Federica Tomao (F)

Department of Gynaecological, Obstetrical and Urological Science, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

Claudia Marchetti (C)

Department of Gynaecological, Obstetrical and Urological Science, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

Emanuela Anastasi (E)

Department of Molecular Medicine, Umberto I Hospital, "La Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.

Andrea Laghi (A)

Department of Radiological, Oncological and Pathological Science, Sant'Andrea Hospital, "La Sapienza" University of Rome, Via di Grottarossa 1035, 00189, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH